EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer’s Disease

Justyna Pokrzyk, Agnieszka Kulczyńska-Przybik iD, Ewa Guzik-Makaruk iD, Izabela Winkel, Barbara Mroczko iD

International Journal of Molecular Sciences · 24.02.2025 · 26 (5) · 1935

DOI: 10.3390/ijms26051935 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.02.2025. Verfasst von Justyna Pokrzyk und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodegeneration Diagnostics, Medical University of Białystok, 15-269 Bialystok, Poland. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Univerity of Białystok, Medical University of Bialystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of amyloid beta peptide (Aβ) in memory regulation has been a subject of substantial interest and debate in neuroscience, because of both physiological and clinical issues. Understanding the dual nature of Aβ in memory regulation is crucial for developing effective treatments for Alzheimer’s disease (AD). Moreover, accurate detection and quantification methods of Aβ isoforms have been tested for diagnostic purposes and therapeutic interventions. This review provides insight into the current knowledge about the methods of amyloid beta detection in vivo and in vitro by fluid tests and brain imaging methods (PET), which allow for preclinical recognition of the disease. Currently, the priority in the development of new therapies for Alzheimer’s disease has been given to potential changes in the progression of the disease. In light of increasing amounts of data, this review was focused on the diagnostic and therapeutic employment of amyloid beta in Alzheimer’s disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesHumansAnimalsPositron-Emission TomographyBrainBiomarkersClinical Relevance

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloid PETamyloid betaamyloid bloodneurodegenerative disease

Substanzen

Amyloid beta-PeptidesBiomarkers

Autor:innen und Institutionen

  • Department of Neurodegeneration Diagnostics, Medical University of Białystok, 15-269 Bialystok, Poland.
  • Faculty of Law, University of Bialystok, 15-213 Białystok, Poland.
  • Dementia Disorders Centre, Medical University of Wroclaw, 50-425 Ścinawa, Poland.
  • Department of Biochemical Diagnostics, Medical University of Białystok, 15-269 Bialystok, Poland.

ORCID-Profile: Agnieszka Kulczyńska-Przybik, Ewa Guzik-Makaruk, Barbara Mroczko

Förderung

  • Medical Univerity of Białystok
  • Medical University of Bialystok

Zitieren

APA

Pokrzyk, J., Kulczyńska-Przybik, A., Guzik-Makaruk, E., Winkel, I., & Mroczko, B. (2025). Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences, 26(5), 1935. https://doi.org/10.3390/ijms26051935

Vancouver

Pokrzyk J, Kulczyńska-Przybik A, Guzik-Makaruk E, Winkel I, Mroczko B. Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer’s Disease. International Journal of Molecular Sciences. 2025;26(5):1935. doi:10.3390/ijms26051935

BibTeX
@article{Pokrzyk2025,
  author = {Pokrzyk, Justyna and Kulczyńska-Przybik, Agnieszka and Guzik-Makaruk, Ewa and Winkel, Izabela and Mroczko, Barbara},
  title = {Clinical Importance of Amyloid Beta Implication in the Detection and Treatment of Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {1935},
  doi = {10.3390/ijms26051935}
}
Kostenlos starten →